| 1645 |
National Cancer Institute |
Html |
en |
Gonzalez Regimen (PDQ®)–Patient Version |
Expert-reviewed information summary about the Gonzalez regimen as a treatment for people with cancer.
Note: The information in this summary is no longer being updated and is provided for reference purposes only. |
| metabolic type | 0.635617 |
| cancer prevention | 0.611486 |
| NCI Best Case | 0.598906 |
| mainstream medical community | 0.586423 |
| scientific methods | 0.589903 |
| PDQ cancer information | 0.678785 |
| Cancer Complementary | 0.593506 |
| pancreatic cancer | 0.652631 |
| CAM therapies | 0.667976 |
| treatment clinical trials | 0.608837 |
| National Cancer Institute | 0.779385 |
| clinical trials | 0.720584 |
| important body processes | 0.609904 |
| alternative medicine | 0.70039 |
| NIH National Library | 0.589764 |
| cancer information summary | 0.665644 |
| alternative cancer therapies | 0.639162 |
| advanced pancreatic cancer | 0.627348 |
| clinical trial | 0.631473 |
| National Center | 0.597871 |
| PubMed bibliographic database | 0.587523 |
| new treatment | 0.61493 |
| breast cancer prevention | 0.609001 |
| certain scientific questions | 0.59076 |
|
| patients | 0.729305 |
| cancer patients | 0.591541 |
| 7-year clinical study | 0.608255 |
| latest published information | 0.596234 |
| Gonzalez regimen | 0.972553 |
| easy-to-use search tool | 0.586572 |
| Integrative Health | 0.595025 |
| NCI PDQ cancer | 0.643516 |
| cancer information database | 0.621215 |
| Health care professionals | 0.588662 |
| alternative therapies | 0.621194 |
| purely alternative approaches | 0.593886 |
| complementary therapies | 0.587662 |
| Gonzalez regimen group | 0.693146 |
| New York physician | 0.598832 |
| health professional versions | 0.595534 |
| prospective studies | 0.59024 |
| cancer | 0.820591 |
| research studies | 0.596285 |
| Nicholas Gonzalez | 0.593123 |
| conventional treatments | 0.632214 |
| Dr. Gonzalez | 0.59152 |
| small number | 0.597616 |
|
CLICK HERE |
| 1711 |
National Cancer Institute |
Html |
en |
Breast Cancer Risk in American Women |
A fact sheet that provides statistics about a woman’s risk of developing breast cancer and information about breast cancer risk factors. |
| current incidence rates | 0.345094 |
| Physical activity level | 0.337892 |
| woman’s risk | 0.354657 |
| certain genes | 0.34342 |
| breast cancer increases | 0.425903 |
| Certain breast changes | 0.409974 |
| Mammographic breast density | 0.411613 |
| Indian/Alaska Native women | 0.346578 |
| breast biopsies | 0.390019 |
| Breast Cancer Risk | 0.442755 |
| following risk factors | 0.34953 |
| close male blood | 0.336852 |
| slightly increased risk | 0.378351 |
| lifetime risk | 0.357498 |
| fatty tissue | 0.342031 |
| average American woman | 0.385569 |
| fatty tissue increases | 0.340815 |
| menopausal hormone therapy | 0.39484 |
| current incidence | 0.346194 |
| women | 0.441907 |
| United States | 0.390167 |
| atypical hyperplasia | 0.338604 |
| individual woman | 0.344493 |
| percent | 0.39834 |
|
| full-term pregnancy | 0.359972 |
| breast cancers | 0.393892 |
| specific ages | 0.341748 |
| dense breasts | 0.348222 |
| breast ducts | 0.38994 |
| breast tissue | 0.419467 |
| National Cancer Institute | 0.363645 |
| progestin menopausal hormone | 0.339022 |
| higher risk | 0.34662 |
| strongest risk factor | 0.391772 |
| breast cancer screening | 0.434635 |
| recent SEER Cancer | 0.368992 |
| breast cancer | 0.950607 |
| dense breast tissue | 0.413692 |
| annual SEER reports | 0.34791 |
| risk factor levels | 0.353691 |
| current incidence rate | 0.341921 |
| slight changes | 0.340621 |
| family history | 0.345271 |
| breast cancer incidence | 0.450564 |
| risk | 0.535827 |
| specific time periods | 0.377721 |
| 10-year age intervals | 0.347265 |
| breast cancer statistics | 0.446445 |
|
CLICK HERE |
| 1787 |
National Cancer Institute |
Html |
es |
Prurito (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del prurito (picazón de la piel) como complicación del cáncer y su tratamiento. Se consideran los abordajes de manejo y tratamiento del prurito. |
| funcionamiento renal | 0.688505 |
| cabo pruebas | 0.675786 |
| PDQ Prurito | 0.877657 |
| siguientes aspectos | 0.726626 |
| Diabetes mellitus | 0.704562 |
| Physician Data Query | 0.887758 |
| distintos tipos | 0.680313 |
| Tide Free | 0.679893 |
| cuidado personal | 0.819492 |
| lÃquidos suavizantes | 0.680081 |
| All Free Clear | 0.98679 |
|
| suficientes lÃquidos | 0.704436 |
| largo plazo | 0.693554 |
| medicamentos corticoesteroideos | 0.689382 |
| toallitas suavizantes | 0.68595 |
| determinada afección | 0.743233 |
| National Cancer Institute | 0.676484 |
| bastantes lÃquidos ayuda | 0.75946 |
| siguientes riesgos | 0.661829 |
| siguientes pruebas | 0.722274 |
| ropa all free | 0.721127 |
| Instituto Nacional | 0.734946 |
|
CLICK HERE |
| 1842 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de endometrio (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de endometrio. |
| Endometrial Cancer Group | 0.318951 |
| Obstet Gynecol | 0.338539 |
| papillary serous carcinoma | 0.328892 |
| uterine papillary serous | 0.337487 |
| positive peritoneal cytology | 0.310059 |
| with low-risk stage | 0.308461 |
| endometrial carcinoma | 0.512882 |
| prognostic factors | 0.307871 |
| Radiat Oncol Biol | 0.365388 |
| surgical staging | 0.309654 |
| laparoscopy versus laparotomy | 0.308759 |
| oncology group study | 0.336362 |
| endometrio estadio | 0.314607 |
| prognostic significance | 0.310042 |
| Natl Cancer Inst | 0.338736 |
| Gynecologic Oncology Group | 0.394499 |
| cancer staging | 0.313796 |
| Gynecol Oncol | 0.593302 |
| patients with | 0.367043 |
| radiation therapy | 0.313526 |
| Braquiterapia vaginal posoperatoria | 0.30677 |
| endometrial cancer | 0.978339 |
| peritoneal cytology | 0.312286 |
| stage-1 endometrial carcinoma | 0.31493 |
| cases with carcinoma | 0.307561 |
|
| Operative Radiation Therapy | 0.306859 |
| Lancet Oncol | 0.306692 |
| with endometrial carcinoma | 0.344016 |
| Danish Endometrial Cancer | 0.332392 |
| estadio iv | 0.31911 |
| estadio ii | 0.371493 |
| with surgical stage | 0.316597 |
| Cancer Staging Manual | 0.308545 |
| Féderation Internationale | 0.308609 |
| endometrial carcinoma only | 0.316396 |
| Endometrial Cancer Study | 0.319041 |
| stage i-ii papillary | 0.306581 |
| endometrial carcinoma among | 0.316625 |
| Clin Oncol | 0.320098 |
| surgical stage | 0.327711 |
| Oncol Biol Phys | 0.368458 |
| Cancer Genome Atlas | 0.314564 |
| estadio iii | 0.309959 |
| clinical stage | 0.315784 |
| cuello uterino | 0.329408 |
| Gynecol Cancer | 0.309855 |
| vaginal brachytherapy | 0.308102 |
| treated with | 0.309769 |
| with or without | 0.308543 |
|
CLICK HERE |
| 2003 |
National Cancer Institute |
Html |
es |
Tratamiento de los tumores de estroma gastrointestinal (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento de los tumores de estroma gastrointestinal |
| Corless CL | 0.538141 |
| Gastric stromal sarcoma | 0.50605 |
| stromal tumors irrespective | 0.50378 |
| Gastrointestinal pacemaker | 0.510002 |
| cases with | 0.505031 |
| Demetri GD | 0.510561 |
| antÃgeno cd117 | 0.5043 |
| stromal tumors but | 0.503793 |
| Sin embargo | 0.508884 |
| KIT-negative gastrointestinal | 0.505275 |
| gastrointestinal stromal sarcomas | 0.507782 |
| gen kit | 0.50569 |
| Cancer Res | 0.504191 |
| sclerosing stromal tumors | 0.504057 |
| receptor kit | 0.508691 |
| with mutational analysis | 0.504267 |
| stromal tumor patient | 0.504863 |
| Multiple gastrointestinal | 0.505317 |
| before imatinib with | 0.505687 |
| PDGFRA activating mutations | 0.504562 |
| Oncol Rep | 0.503948 |
| nervioso autónomo gastrointestinal | 0.506079 |
| interstitial cells | 0.505694 |
| TEGI primario recién | 0.504948 |
| new cases with | 0.504631 |
|
| verdadero tegi | 0.504221 |
| stromal tumor occurs | 0.504698 |
| gastric stromal tumours | 0.506473 |
| microscopic gastrointestinal | 0.505987 |
| gastrointestinal tract | 0.505493 |
| gastrointestinal stromal tumors | 0.979159 |
| Surg Pathol | 0.538619 |
| Duensing A | 0.505663 |
| tumors have unique | 0.505149 |
| molecular genetic study | 0.50922 |
| Cancer Staging Manual | 0.525628 |
| tirosina cinasa kit | 0.507752 |
| tirosina cinasa | 0.607449 |
| proteÃna cinasa | 0.508725 |
| Heinrich MC | 0.512562 |
| carney triad | 0.506455 |
| gastrointestinal stromal tumours | 0.529292 |
| with long-term follow-up | 0.503857 |
| stromal sarcoma | 0.507115 |
| metastatic gastrointestinal | 0.505468 |
| NF1-associated gastrointestinal | 0.509992 |
| ANNUAL REVIEWS | 0.505692 |
| pacemaker cell tumor | 0.506911 |
| AJCC Cancer Staging | 0.518324 |
|
CLICK HERE |
| 2974 |
National Cancer Institute |
Video |
en |
Challenge: Fitting fitness into your busy schedule |
Life can get really hectic sometimes. Between work, family and other obligations, it's hard to find time to exercise. But before you say you don't have time to exercise each day, consider this: even a little bit of exercise is better than no exercise at all! |
| little bit | 0.820288 |
| fitness | 0.392435 |
| work | 0.370295 |
| obligations | 0.461065 |
|
| Life | 0.388039 |
| exercise | 0.667358 |
| time | 0.674488 |
| family | 0.369813 |
|
CLICK HERE |
| 3768 |
National Cancer Institute |
Html |
en |
NCI Research Specialist Award (R50) |
Award enables scientists to pursue stable research careers within an existing cancer research program, but not serve as independent investigators. Letter of Intent due: January 2, 2017 Application due: February 2, 2017 |
| Research Specialist Award | 0.988915 |
| core-based scientists | 0.581471 |
| grant applications | 0.550206 |
| stable research career | 0.730099 |
| NCI-funded cancer research | 0.716667 |
| PM local time | 0.654064 |
| Funding Opportunity Announcements | 0.676968 |
| context | 0.428705 |
| FOA | 0.51866 |
| laboratory-based scientists | 0.56909 |
| sufficient autonomy | 0.601601 |
| grants | 0.427207 |
| cancer research program | 0.718023 |
| development | 0.427246 |
|
| data scientists | 0.569495 |
| researchers | 0.4266 |
| biomedical research enterprise. | 0.720253 |
| Intent | 0.437384 |
| R50 | 0.455052 |
| opportunities | 0.427151 |
| exceptional scientists | 0.586489 |
| applicant organization | 0.552188 |
| Principal Investigators | 0.571254 |
| core facility managers | 0.705581 |
| NCI Research Specialist | 0.740871 |
| career continuity | 0.565048 |
| FOAs | 0.534084 |
| independent investigators. | 0.567464 |
|
CLICK HERE |
| 15636 |
National Cancer Institute |
Html |
null |
Step 6: Post-Award Administration |
Information on numerous requirements that must be met in order to to be in compliance with NIH policy after receiving an award. This includes implementing monitoring systems and keeping financial and programmatic records. |
|
|
CLICK HERE |
| 16254 |
National Cancer Institute |
Html |
es |
Genómica del cáncer |
La investigación de fundamentos genéticos del cáncer ha mejorado nuestro entendimiento de la biología del cáncer y ha conducido a nuevos métodos de diagnosticar y tratar la enfermedad. |
| colores vibrantes | 0.499759 |
| programas de investigación | 0.654055 |
| posibles genes | 0.505721 |
| próxima generación | 0.497158 |
| prácticas de participación | 0.488897 |
| cambios genómicos que | 0.533603 |
| NCI al hacerlos | 0.685799 |
| gen braf | 0.523508 |
| cáncer y programas | 0.967985 |
| proteÃnas. el nci | 0.703749 |
| gen her2 | 0.525613 |
| investigadores representaciones | 0.514115 |
| facilidad de acceso | 0.490645 |
| alta calidad | 0.874691 |
| lÃnea germinal y exposiciones | 0.549891 |
|
| el instituto nacional | 0.489007 |
| cuáles tratamientos | 0.520412 |
| pequeño porcentaje | 0.500295 |
| Genoma Humano | 0.547332 |
| pacientes correctos | 0.574878 |
| tratamientos en investigación | 0.520771 |
| genes candidatos | 0.501572 |
| tratamientos correctos | 0.52447 |
| Estudios ClÃnicos del NCI | 0.817174 |
| determinada terapia | 0.501736 |
| rasgos genómicos y el | 0.775836 |
| mutaciones impulsoras | 0.525134 |
| la investigación aplicable | 0.503499 |
| datos estén | 0.521046 |
|
CLICK HERE |
| 16257 |
National Cancer Institute |
Html |
es |
Prevención |
La investigación del NCI de prevención va desde identificación de factores ambientales y de estilos de vida que influyen en el riesgo de cáncer hasta la biología de la formación del cáncer y la evaluación para diseminar intervenciones de prevención. |
| próxima generación | 0.432035 |
| Mejor reducción | 0.436692 |
| Investigación Nacional Colaborativa | 0.455747 |
| Investigación Oncológica | 0.43883 |
| Nuevos planteamientos | 0.440499 |
| investigación sustancias | 0.43567 |
| Estudio Vida Familiar | 0.45233 |
| Estados Unidos | 0.908876 |
| numerosos factores | 0.443836 |
| cabo estudios | 0.446295 |
| Cáncer apoya programas | 0.610288 |
|
| cánceres más | 0.43473 |
| numerosos estudios | 0.443241 |
| posibles terapias | 0.437443 |
| Pre-Cancer Atlas | 0.437082 |
| el uso | 0.430938 |
| inmensa complejidad | 0.437794 |
| amplio rango | 0.43275 |
| prevención del cáncer del nci | 0.509541 |
| creación de vacunas | 0.467866 |
| prueba formas | 0.434098 |
| Estados Unidos gastarán | 0.466237 |
|
CLICK HERE |